Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Product Sales Performance
AMGN logo

Amgen Reports 6% Revenue Growth to $8.6 Billion Driven by 9% Volume Surge

AMGN8-KFiling Date: 4/30/2026
Amgen Inc.
Description

What this story covers

Amgen’s Q1 2026 results show a 6% revenue increase to $8.6 billion, fueled by strong volume growth in new oncology and rare disease therapies. Despite pricing pressures and mature product erosion, the company reaffirmed confident full-year earnings guidance.

Story snapshot

CompanyAmgen Inc.
TickerAMGN
VariantStandard detailed
Duration6:47
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000318154-26-000054
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in